Teneliximab

Teneliximab is a chimeric monoclonal antibody^[1] binding to the immune stimulatory protein CD40.^[2] As of 2009^[update], it has not entered clinical trials.^[2]

Teneliximab

Monoclonal antibody
Type	Whole antibody
Source	Chimeric (mouse/human)
Target	CD40
Clinical data
ATC code	none
Identifiers
CAS Number	299423-37-3 N
ChemSpider	none
UNII	G0MV33WQ6V
KEGG	D06071 Y
NY (what is this?)  (verify)